XML 69 R38.htm IDEA: XBRL DOCUMENT v3.20.1
Stock-Based Compensation - Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Stock-Based Compensation    
Available for grant (in shares) 331,607  
Share-based compensation costs recognized $ 3,142 $ 3,082
Remaining unamortized expense $ 2,772  
Remaining unamortized expense period 1 year 3 months 18 days  
Research and development expense    
Stock-Based Compensation    
Share-based compensation costs recognized $ 1,791 1,843
General and administrative expense    
Stock-Based Compensation    
Share-based compensation costs recognized $ 1,351 1,239
Options    
Stock-Based Compensation    
Number of options granted (in shares) 384,800  
Share-based compensation costs recognized $ 3,070 2,872
Options | BioXcel Corporation    
Stock-Based Compensation    
Share-based compensation costs recognized $ 72 $ 210